Category

Clinical Trials

NK cells cancer

XNK Therapeutics enters joint Phase II study

February 26, 2021

XNK Therapeutics is entering into …

Johan Drott

Diaprost announces promising results

February 22, 2021

Diaprost has announced a publication …

Sara Mangsbo Photo Mikael Wallerstedt

First patient treated in Ultimovacs TENDU study

February 18, 2021

Ultimovacs has announced the treatment …

Christine W B

Nordic Nanovector provides Phase II trial update

February 18, 2021

Nordic Nanovector provides an update …

Annette Säfholm

First patient enrolled in Gedea study

February 17, 2021

Gedea Biotech has enrolled the …

Pilloxa and University of Oslo start collaborative trial

February 17, 2021

Pilloxa has announced the start …

Patric Stenberg

Gesynta Pharma initiates Phase II study

January 27, 2021

Gesynta Pharma has announced that …

Nanoform

Positive interim results from Nanoform study

January 26, 2021

Nanoform has announced positive interim …

Lytix Biopharma receives FDA clearance to initiate Phase II study

January 20, 2021

Lytix Biopharma has announced that …

#D illustration of ovarian cancer

Ultimovacs announces Phase II collaboration study in ovarian cancer

January 14, 2021

Ultimovacs will participate in the …

Evelina Vågesjö

Positive results from Ilya’s Phase I trial

January 14, 2021

Ilya Pharma has announced positive …

Edward Haeggstrom

First dosing of nanoformed drug successfully accomplished

January 8, 2021

Nanoform has announced that the …

Klaas Bakker

Oncopeptides enrolls the first patient in phase 3 study

January 8, 2021

Oncopeptides has announced that the …

Carlos de Sousa

Ultimovacs initiates Phase II trial

December 30, 2020

Ultimovacs has announced the initiation …

Novo Nordisk to enter phase 3 development in Alzheimer’s disease

December 28, 2020

Novo Nordisk has announced the …

Sven Rohmann Immunicum

Immunicum completes patient recruitment for Phase Ib trial

December 21, 2020

Immunicum has announced the completion …

1
2
3
4
···
35